chr11-5788671-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001001913.2(OR52N1):āc.146A>Gā(p.Tyr49Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000316 in 1,613,768 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001001913.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OR52N1 | NM_001001913.2 | c.146A>G | p.Tyr49Cys | missense_variant | 2/2 | ENST00000641645.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OR52N1 | ENST00000641645.1 | c.146A>G | p.Tyr49Cys | missense_variant | 2/2 | NM_001001913.2 | P1 | ||
TRIM5 | ENST00000412903.1 | c.-61-108433A>G | intron_variant | 1 | |||||
TRIM5 | ENST00000380027.5 | c.-441+67081A>G | intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.000230 AC: 35AN: 152084Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000638 AC: 16AN: 250598Hom.: 0 AF XY: 0.0000591 AC XY: 8AN XY: 135386
GnomAD4 exome AF: 0.0000109 AC: 16AN: 1461684Hom.: 0 Cov.: 39 AF XY: 0.00000688 AC XY: 5AN XY: 727146
GnomAD4 genome AF: 0.000230 AC: 35AN: 152084Hom.: 0 Cov.: 32 AF XY: 0.000229 AC XY: 17AN XY: 74288
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 24, 2022 | The c.146A>G (p.Y49C) alteration is located in exon 1 (coding exon 1) of the OR52N1 gene. This alteration results from a A to G substitution at nucleotide position 146, causing the tyrosine (Y) at amino acid position 49 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at